174 related articles for article (PubMed ID: 37531786)
1. Molecular landscape of LncRNAs in bladder cancer: From drug resistance to novel LncRNA-based therapeutic strategies.
Mehmandar-Oskuie A; Jahankhani K; Rostamlou A; Arabi S; Sadat Razavi Z; Mardi A
Biomed Pharmacother; 2023 Sep; 165():115242. PubMed ID: 37531786
[TBL] [Abstract][Full Text] [Related]
2. Long non-coding RNAs as new players in bladder cancer: Lessons from pre-clinical and clinical studies.
Mirzaei S; Paskeh MDA; Hashemi F; Zabolian A; Hashemi M; Entezari M; Tabari T; Ashrafizadeh M; Raee P; Aghamiri S; Aref AR; Leong HC; Kumar AP; Samarghandian S; Zarrabi A; Hushmandi K
Life Sci; 2022 Jan; 288():119948. PubMed ID: 34520771
[TBL] [Abstract][Full Text] [Related]
3. Long noncoding RNAs, ENST00000598996 and ENST00000524265, are correlated with favorable prognosis and act as potential tumor suppressors in bladder cancer.
Shen C; Wang Y; Wu Z; Da L; Gao S; Xie L; Qie Y; Wang Y; Zhang Z; Tian D; Hu H
Oncol Rep; 2020 Nov; 44(5):1831-1850. PubMed ID: 33000254
[TBL] [Abstract][Full Text] [Related]
4. Long noncoding RNA in prostate, bladder, and kidney cancer.
Martens-Uzunova ES; Böttcher R; Croce CM; Jenster G; Visakorpi T; Calin GA
Eur Urol; 2014 Jun; 65(6):1140-51. PubMed ID: 24373479
[TBL] [Abstract][Full Text] [Related]
5. lncRNA H19 regulates epithelial-mesenchymal transition and metastasis of bladder cancer by miR-29b-3p as competing endogenous RNA.
Lv M; Zhong Z; Huang M; Tian Q; Jiang R; Chen J
Biochim Biophys Acta Mol Cell Res; 2017 Oct; 1864(10):1887-1899. PubMed ID: 28779971
[TBL] [Abstract][Full Text] [Related]
6. Expression of the Long Non-Coding RNA HOTAIR Correlates with Disease Progression in Bladder Cancer and Is Contained in Bladder Cancer Patient Urinary Exosomes.
Berrondo C; Flax J; Kucherov V; Siebert A; Osinski T; Rosenberg A; Fucile C; Richheimer S; Beckham CJ
PLoS One; 2016; 11(1):e0147236. PubMed ID: 26800519
[TBL] [Abstract][Full Text] [Related]
7. The prognostic significance of long noncoding RNAs in bladder cancer: A meta-analysis.
Xia Y; Liu Z; Yu W; Zhou S; Shao L; Song W; Liu M
PLoS One; 2018; 13(6):e0198602. PubMed ID: 29870555
[TBL] [Abstract][Full Text] [Related]
8. Identification of glycolysis-associated long non-coding RNA regulatory subtypes and construction of prognostic signatures by transcriptomics for bladder cancer.
Mao C; Gao Y; Wan M; Xu N
Funct Integr Genomics; 2022 Aug; 22(4):597-609. PubMed ID: 35420332
[TBL] [Abstract][Full Text] [Related]
9. lncRNA MIR503HG functioned as a tumor suppressor and inhibited cell proliferation, metastasis and epithelial-mesenchymal transition in bladder cancer.
Qiu F; Zhang MR; Zhou Z; Pu JX; Zhao XJ
J Cell Biochem; 2019 Jun; 120(6):10821-10829. PubMed ID: 30672010
[TBL] [Abstract][Full Text] [Related]
10. Role of Long Non-coding RNAs on Bladder Cancer.
Li HJ; Gong X; Li ZK; Qin W; He CX; Xing L; Zhou X; Zhao D; Cao HL
Front Cell Dev Biol; 2021; 9():672679. PubMed ID: 34422802
[TBL] [Abstract][Full Text] [Related]
11. Molecular mechanism of microRNAs, long noncoding RNAs, and circular RNAs regulating lymphatic metastasis of bladder cancer.
Zengzhao W; Xuan L; Xiaohan M; Encun H; Jibing C; Hongjun G
Urol Oncol; 2024 Jan; 42(1):3-17. PubMed ID: 37989693
[TBL] [Abstract][Full Text] [Related]
12. Tetracycline-inducible shRNA targeting antisense long non-coding RNA HIF1A-AS2 represses the malignant phenotypes of bladder cancer.
Chen M; Zhuang C; Liu Y; Li J; Dai F; Xia M; Zhan Y; Lin J; Chen Z; He A; Xu W; Zhao G; Guo Y; Cai Z; Huang W
Cancer Lett; 2016 Jun; 376(1):155-64. PubMed ID: 27018306
[TBL] [Abstract][Full Text] [Related]
13. Identification of oncogenic long noncoding RNA SNHG12 and DUXAP8 in human bladder cancer through a comprehensive profiling analysis.
Jiang B; Hailong S; Yuan J; Zhao H; Xia W; Zha Z; Bin W; Liu Z
Biomed Pharmacother; 2018 Dec; 108():500-507. PubMed ID: 30243082
[TBL] [Abstract][Full Text] [Related]
14. Long Non-Coding RNA Expression Profiles for the Characterization of Different Bladder Cancer Grade.
Cao YP; Zhou J; Li WJ; Shao Y; Zheng SY; Tian T; Xie KP; Yan X
Cell Physiol Biochem; 2018; 50(3):1154-1163. PubMed ID: 30355928
[TBL] [Abstract][Full Text] [Related]
15. Explore prognostic biomarker of bladder cancer based on competing endogenous network.
Li F; Guo H; Liu B; Liu N; Xu Z; Wang Y; Zhou H
Biosci Rep; 2020 Dec; 40(12):. PubMed ID: 33169791
[TBL] [Abstract][Full Text] [Related]
16. Biological functions and clinical significance of long noncoding RNAs in bladder cancer.
Zhang Y; Chen X; Lin J; Jin X
Cell Death Discov; 2021 Oct; 7(1):278. PubMed ID: 34611133
[TBL] [Abstract][Full Text] [Related]
17. High LINC01605 expression predicts poor prognosis and promotes tumor progression via up-regulation of MMP9 in bladder cancer.
Qin Z; Wang Y; Tang J; Zhang L; Li R; Xue J; Han P; Wang W; Qin C; Xing Q; Yang J; Zhang W
Biosci Rep; 2018 Oct; 38(5):. PubMed ID: 30054424
[TBL] [Abstract][Full Text] [Related]
18. LINC00612 enhances the proliferation and invasion ability of bladder cancer cells as ceRNA by sponging miR-590 to elevate expression of PHF14.
Miao L; Liu HY; Zhou C; He X
J Exp Clin Cancer Res; 2019 Apr; 38(1):143. PubMed ID: 30940184
[TBL] [Abstract][Full Text] [Related]
19. A prognostic risk prediction model based on ferroptosis-related long non-coding RNAs in bladder cancer: A bulk RNA-seq research and scRNA-seq validation.
Xiang X; Guo Y; Chen Z; Zhang F; Huang J; Qin Y
Medicine (Baltimore); 2022 Dec; 101(51):e32558. PubMed ID: 36595859
[TBL] [Abstract][Full Text] [Related]
20. Long non-coding RNA in bladder cancer.
Cao Y; Tian T; Li W; Xu H; Zhan C; Wu X; Wang C; Wu X; Wu W; Zheng S; Xie K
Clin Chim Acta; 2020 Apr; 503():113-121. PubMed ID: 31940466
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
